Alerts will be sent to your verified email
Verify Email
WOCKPHARMA
|
Wockhardt
|
JB Chem & Pharma
|
Gland Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
10.6 % | 10.1 % | n/a |
|
R&D as a % of Total Sales
|
2.9 % | 1.35 % | 4.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
4.06 % | 17.95 % | 12.02 % |
|
5yr average Equity Multiplier
|
2.02 | 1.51 | 1.15 |
|
5yr Average Asset Turnover Ratio
|
0.39 | 0.76 | 0.51 |
|
5yr Avg Net Profit Margin
|
-4.28 % | 15.74 % | 20.79 % |
|
Price to Book
|
6.46 | 8.66 | 3.68 |
|
P/E
|
149.8 | 50.78 | 37.15 |
|
5yr Avg Cash Conversion Cycle
|
-94.15 Days | 15.08 Days | 69.81 Days |
|
Inventory Days
|
61.29 Days | 50.96 Days | 118.26 Days |
|
Days Receivable
|
60.36 Days | 72.72 Days | 99.92 Days |
|
Days Payable
|
251.45 Days | 94.5 Days | 107.43 Days |
|
5yr Average Interest Coverage Ratio
|
-0.43 | 76.53 | 183.05 |
|
5yr Avg ROCE
|
-0.28 % | 20.71 % | 16.55 % |
|
5yr Avg Operating Profit Margin
|
5.03 % | 24.61 % | 29.26 % |
|
5 yr average Debt to Equity
|
0.56 | 0.07 | 0.01 |
|
5yr CAGR Net Profit
|
n/a | 12.98 % | -6.87 % |
|
5yr Average Return on Assets
|
-1.79 % | 11.91 % | 10.65 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.08 % | 48.8 % | 51.83 % |
|
Share Pledged by Promoters
|
18.82 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-10.23 % | -5.13 % | -6.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
8.12 % | 2.83 % | 11.53 % |
|
Wockhardt
|
JB Chem & Pharma
|
Gland Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|